ABSI (A Body Shape Index)
Biomarkers
The contribution of abdominal fat to body shape
A Body Shape Index is a measure that isolates the contribution of waist circumference (abdominal fat) to body shape, adjusted for height and BMI. A high ABSI is linked to greater health risk independently of weight. The result is interpreted as a z-score relative to people of the same sex and age.
ALT (alanine aminotransferase)
Biomarkers
A liver enzyme; a marker of liver-cell damage
ALT (alanine aminotransferase) is an enzyme located mainly inside liver cells. When they are damaged, ALT leaks into the blood, so its rise is a sensitive sign of liver problems (fatty liver, hepatitis, the effects of alcohol and medications).
AMPK
Biochemistry
The cellular "energy sensor" that switches on when energy is scarce
AMPK (AMP-activated protein kinase) is an enzyme that is activated when the cell's energy store falls (fasting, exertion) and shifts metabolism into an economy mode: it enhances autophagy and fat burning and suppresses mTOR. It is considered one of the key mediators of the beneficial effects of fasting and physical activity.
ASCVD (Atherosclerotic cardiovascular disease)
Indices & scales
Atherosclerotic Cardiovascular Disease — the group of conditions caused by atherosclerosis: heart attack, stroke, coronary heart disease.
ASCVD includes: non-fatal myocardial infarction, death from coronary heart disease, and non-fatal or fatal stroke. The Pooled Cohort Equations (ACC/AHA, 2013) estimate the 10-year risk of a first ASCVD event in people without existing cardiovascular disease. At a risk of ≥7.5%, a discussion of statin therapy is recommended. The equations were derived from data on more than 500,000 participants in the NHLBI cohort studies.
AST (aspartate aminotransferase)
Biomarkers
An enzyme of the liver, heart and muscles; a marker of tissue damage
AST (aspartate aminotransferase) is an enzyme found in the liver, heart and muscles. It is less specific to the liver than ALT. The AST/ALT ratio (the De Ritis ratio) helps distinguish the causes of damage; AST is a component of the FIB-4 fibrosis index.
Abdominal obesity
Conditions
Excess fat in the abdominal area
Abdominal (central) obesity is the predominant accumulation of fat around the waist and internal organs. It is defined by waist circumference independently of BMI and is closely linked to metabolic syndrome and cardiovascular risk.
Acanthosis nigricans
Conditions
Dark, velvety patches of skin — a marker of insulin resistance
Acanthosis nigricans is darkened, velvety-to-the-touch patches of skin on the neck, armpits and groin. It is a common skin sign of insulin resistance and metabolic syndrome.
Aging rate coefficient
Indices & scales
How many times the pace of aging differs from normal
A measure from the Gorelkin–Pinkhasov method: the ratio of the body's actual age-related "wear" to the norm. Values of 0.95–1.05 are a physiological pace; below 0.95 is slowed aging; above 1.05 is accelerated. It is calculated from the waist-to-hip ratio and the body mass index, adjusted for age and sex.
Albumin
Biomarkers
The main plasma protein — a marker of protein status and liver function
Albumin is the most abundant plasma protein (60% of total protein) and is synthesized in the liver. It maintains the blood's oncotic pressure and transports drugs, hormones and fatty acids. Normal range: 35–52 g/L. It falls with liver disease, malnutrition, nephrotic syndrome and chronic inflammation. A drop in albumin is one of the strongest predictors of mortality in older people and enters the PhenoAge and Bortz Blood Age formulas with a negative coefficient (higher albumin — a younger biological age).
Albuminuria (microalbuminuria)
Biomarkers
The appearance of albumin protein in the urine — an early sign of glomerular damage that precedes overt kidney failure.
Normal range: <30 mg/g creatinine. Microalbuminuria (30–300 mg/g) is detected in diabetes and hypertension long before GFR declines. It is a marker of endothelial dysfunction and increased cardiovascular risk.
Alcoholic liver disease (ALD)
Conditions
Liver damage due to alcohol consumption
Alcoholic Liver Disease (ALD) is a spectrum of liver damage caused by alcohol consumption: from fatty liver to alcoholic hepatitis and cirrhosis. The ANI index helps distinguish it from non-alcoholic fatty liver disease by blood tests, especially when the alcohol history is unreliable.
Alkaline phosphatase (ALP)
Biomarkers
an enzyme of the bile ducts and bones, a marker of cholestasis
Alkaline phosphatase (ALP) is an enzyme that in the liver is located in the epithelium of the bile ducts; it is also present in bone, intestine and placenta. It rises when bile outflow is impaired (cholestasis). In the R-factor the multiple of ALP above the upper limit of normal is used; its predominance shifts the result toward a cholestatic pattern. With an isolated rise, the source is clarified by GGT.
Allostatic load
Conditions
The accumulated wear on the body from chronic stress
Allostatic load is the cumulative biological "wear and tear" accrued during prolonged adaptation to stress. When the body mobilizes the stress response again and again (raising cortisol, blood pressure and inflammatory markers), that activation comes at the cost of accelerated aging of organs and systems. A high allostatic load is associated with accelerated epigenetic aging (GrimAge) and with the risk of cardiovascular disease, dementia and metabolic disorders. It includes 10+ biomarkers: cortisol, IL-6, CRP, blood pressure, BMI, HbA1c.
Alzheimer's disease
Conditions
A neurodegenerative disease — the most common cause of dementia.
Alzheimer's disease is a progressive neurodegenerative disorder characterized by the accumulation of β-amyloid plaques and tau-protein neurofibrillary tangles in the brain. It accounts for 60–70% of all dementia cases. Main symptoms: progressive amnesia, speech impairment, disorientation and personality changes. Early biomarkers: β-amyloid 42 and phospho-tau in cerebrospinal fluid or on PET. Elevated homocysteine (>14 µmol/L) nearly doubles the risk of the disease (Framingham Study, NEJM 2002).
Amino acids
Biochemistry
The building blocks of the body's proteins
Organic compounds that are the structural elements of proteins. There are 20 standard amino acids, 9 of which are essential (not synthesized by the body). They participate in the synthesis of hormones, neurotransmitters and immune proteins. Analysis of the amino-acid profile reveals metabolic disorders.
Amyloid (β-amyloid)
Biochemistry
A pathological protein that accumulates in the brain in Alzheimer's disease
β-amyloid (Aβ) is a fragment of the APP protein that is normally cleaved, but in Alzheimer's disease it forms insoluble aggregates — "plaques" between neurons. The accumulation of amyloid plaques triggers inflammation, disrupts synaptic transmission and ultimately leads to neuronal death. The amyloid hypothesis is the leading concept of Alzheimer's pathogenesis. Amyloid levels can be measured by PET scanning or cerebrospinal-fluid analysis.
Android body type ("apple")
Conditions
Fat predominantly on the abdomen
A fat-distribution pattern dominated by deposits around the waist and abdomen (the "apple" shape). It is associated with the accumulation of visceral fat around the organs and with an increased risk of metabolic syndrome, cardiovascular disease and type 2 diabetes. It is more common in men and is reflected in a high WHR.
Anemia
Conditions
A drop in hemoglobin below the normal level
Anemia is a reduced hemoglobin concentration: in women <12 g/dL, in men <13 g/dL (WHO). The most common cause is iron deficiency (iron-deficiency anemia). Other causes: B12/folate deficiency, chronic disease, hemolysis and blood loss. Symptoms: weakness, shortness of breath, pallor and tachycardia. Grades: mild (Hb 10–12/13), moderate (8–10), severe (<8 g/dL).
Antacids
Methods
Drugs that reduce stomach acidity
Antacids and proton-pump inhibitors (omeprazole, pantoprazole) reduce the acidity of gastric juice. Hydrochloric acid is needed to reduce Fe³⁺ → Fe²⁺ and to absorb iron in the duodenum. Long-term use of acid-suppressing drugs lowers iron absorption by 40–70%.
Anti-TPO (thyroid peroxidase antibodies)
Biomarkers
A marker of autoimmune thyroiditis
Antibodies to thyroid peroxidase — an enzyme involved in the synthesis of thyroid hormones. Their elevation is a key sign of Hashimoto's autoimmune thyroiditis and can appear years before TSH shifts. Even low detectable levels warrant monitoring. Normal range 0–34 IU/mL.
Anxiety
Conditions
A pathological state of excessive worry
An emotional state characterized by worry, tension and a sense of impending threat. Anxiety correlates with a high PSS score and elevated cortisol. Clinically significant anxiety is diagnosed by the GAD-7, HADS-A and Beck scales.
Apolipoprotein A1 (ApoA1)
Biomarkers
The main protein of "good" HDL particles; it protects vessels from atherosclerosis
ApoA1 (Apolipoprotein A1) is the main protein component of high-density lipoproteins (HDL), making up 70% of their protein mass. It activates the enzyme LCAT, which carries out reverse cholesterol transport — the removal of cholesterol from vessel walls to the liver. Normal range: men 1.04–2.02 g/L, women 1.08–2.25 g/L. It is a more accurate predictor of cardiovascular risk than HDL cholesterol itself. In the Bortz Blood Age model it enters with a negative coefficient (higher ApoA1 — a younger biological age).
Apoptosis
Biochemistry
Programmed cell death
Apoptosis is a genetically programmed form of cell death, triggered by critical telomere shortening, irreparable DNA damage or signals from the immune system. Unlike necrosis, apoptosis occurs without inflammation — the cell is neatly disassembled into fragments that macrophages engulf. It serves as a protective mechanism against malignant transformation.
Arterial hypertension
Conditions
A sustained rise in blood pressure ≥130/80 mmHg — the leading modifiable risk factor for stroke and heart attack.
By the ACC/AHA 2017 classification: normal <120/80, elevated 120–129/<80, stage 1 hypertension 130–139/80–89, stage 2 hypertension ≥140/90. Hypertension damages the vascular endothelium, accelerates atherosclerosis, causes left-ventricular hypertrophy and raises the risk of kidney failure. It is symptomless until complications arise, which is why it is called the "silent killer". Treatment with antihypertensive drugs lowers stroke risk by ~35–40%.
Atherosclerosis
Conditions
The buildup of cholesterol plaques in artery walls — the main cause of heart attacks and strokes.
A chronic inflammatory disease of the arteries: LDL cholesterol is deposited in the vessel wall, forming an atherosclerotic plaque. The plaque narrows the vessel lumen and can rupture, causing thrombosis. The result is a myocardial infarction or stroke. It develops over decades and shows clinically late. Key risk factors: high LDL, smoking, arterial hypertension and diabetes mellitus.
Atrial fibrillation
Conditions
Chaotic contraction of the atria — the most common arrhythmia
Atrial fibrillation (AF) is a heart-rhythm disorder in which the atria contract chaotically at 350–700 impulses per minute. It raises the risk of stroke fivefold and of heart failure threefold. It is diagnosed by ECG. Prevalence: about 2% of the population, rising sharply after age 65. It is one of the markers of an "old" heart.
Autoimmune thyroiditis (Hashimoto's)
Conditions
The main cause of hypothyroidism in developed countries
Autoimmune thyroiditis (Hashimoto's thyroiditis) is a chronic inflammation in which the immune system gradually destroys the thyroid gland, leading to hypothyroidism. It is confirmed by elevated anti-TPO / anti-TG and often co-occurs with other autoimmune diseases.
Autophagy
Biochemistry
The cell's self-cleaning of damaged components
A cellular process of disposing of and recycling damaged organelles and proteins ("self-eating"). It supports cell renewal and is linked to protection against neurodegeneration and aging. It is activated by calorie restriction and intermittent fasting, by exercise and by nutrient scarcity.